How to buy Ortho Clinical Diagnostics Holdings plc stock (Ortho Clinical Diagnostics Holdings plc)

Ortho Clinical Diagnostics Holdings plc is a diagnostics & research business based in the US. Ortho Clinical Diagnostics Holdings plc shares (OCDX) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $20.23 – a decrease of 1.12% over the previous week. Ortho Clinical Diagnostics Holdings plc employs 4,500 staff and has a trailing 12-month revenue of around $1.9 billion.

Our top picks for where to buy Ortho Clinical Diagnostics stock

Buy Ortho Clinical Diagnostics Holdings plc stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Ortho Clinical Diagnostics Holdings plc stock price (NASDAQ: OCDX)

Use our graph to track the performance of OCDX stocks over time.

Ortho Clinical Diagnostics Holdings plc shares at a glance

• Key figures

Information last updated 2021-05-26.

Latest market close	$20.23
52-week range	$15.14 - $21.82
50-day moving average more info button	$19.71
200-day moving average more info button	$18.56
Wall St. target price	$24.82
PE ratio more info button	N/A
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	N/A

Is it a good time to buy Ortho Clinical Diagnostics Holdings plc stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Ortho Clinical Diagnostics Holdings plc price performance over time

Historical closes compared with the close of $20.09 from 2021-05-25

1 week (2024-10-11)	N/A
1 month (2024-09-18)	N/A
3 months (2024-07-18)	N/A
6 months (2024-04-18)	N/A

1 year (2023-10-18)	N/A
2 years (2022-10-18)	N/A
3 years (2021-10-21)	1.26%
5 years (2019-10-18)	N/A

Is Ortho Clinical Diagnostics Holdings plc stock undervalued or overvalued?

Valuing Ortho Clinical Diagnostics Holdings plc stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Ortho Clinical Diagnostics Holdings plc's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Ortho Clinical Diagnostics Holdings plc's EBITDA

Ortho Clinical Diagnostics Holdings plc's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $438.9 million.

The EBITDA is a measure of a Ortho Clinical Diagnostics Holdings plc's overall financial performance and is widely used to measure a its profitability.

To put Ortho Clinical Diagnostics Holdings plc's EBITDA into context you can compare it against that of similar companies.

• Trinity Biotech (TRIB.US): USD$-11297000
• Meridian Bioscience (VIVO.US): USD$92.1 million
• IDEXX Laboratories (IDXX.US): USD$1.3 billion

Ortho Clinical Diagnostics Holdings plc financials

Revenue TTM	$1.9 billion
Operating margin TTM	8.34%
Gross profit TTM	$880.4 million
Return on assets TTM	1.97%
Return on equity TTM	0%
Profit margin	-8.03%
Book value	N/A
Market Capitalization more info button	$4.7 billion

TTM: trailing 12 months

Shorting Ortho Clinical Diagnostics Holdings plc shares

There are currently 2.7 million Ortho Clinical Diagnostics Holdings plc shares held short by investors – that's known as Ortho Clinical Diagnostics Holdings plc's "short interest". This figure is 10.4% up from 2.4 million last month.

There are a few different ways that this level of interest in shorting Ortho Clinical Diagnostics Holdings plc shares can be evaluated.

Ortho Clinical Diagnostics Holdings plc's "short interest ratio" (SIR)

Ortho Clinical Diagnostics Holdings plc's "short interest ratio" (SIR) is the quantity of Ortho Clinical Diagnostics Holdings plc shares currently shorted divided by the average quantity of Ortho Clinical Diagnostics Holdings plc shares traded daily (recently around 869855.22875817). Ortho Clinical Diagnostics Holdings plc's SIR currently stands at 3.06. In other words for every 100,000 Ortho Clinical Diagnostics Holdings plc shares traded daily on the market, roughly 3060 shares are currently held short.

To gain some more context, you can compare Ortho Clinical Diagnostics Holdings plc's short interest ratio against those of similar companies.

However Ortho Clinical Diagnostics Holdings plc's short interest can also be evaluated against the total number of Ortho Clinical Diagnostics Holdings plc shares, or, against the total number of tradable Ortho Clinical Diagnostics Holdings plc shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Ortho Clinical Diagnostics Holdings plc's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Ortho Clinical Diagnostics Holdings plc shares in existence, roughly 10 shares are currently held short) or 0.0294% of the tradable shares (for every 100,000 tradable Ortho Clinical Diagnostics Holdings plc shares, roughly 29 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Ortho Clinical Diagnostics Holdings plc.

Find out more about how you can short Ortho Clinical Diagnostics Holdings plc stock.

Ortho Clinical Diagnostics Holdings plc share dividends

We're not expecting Ortho Clinical Diagnostics Holdings plc to pay a dividend over the next 12 months.

You may also wish to consider:

Ortho Clinical Diagnostics Holdings plc overview

Ortho Clinical Diagnostics Holdings plc engages in the vitro diagnostics business worldwide. The company offers automated instruments; and assays, reagents, and other consumables that are used by these instruments to generate test results. Its solutions include clinical chemistry and immunoassay instruments and tests to detect and monitor disease progression across a spectrum of therapeutic areas, including COVID-19 antibody and antigen tests; and immunohematology instruments and tests for blood typing to ensure patient-donor compatibility in blood transfusions, as well as donor screening instruments and tests for blood and plasma screening for infectious diseases. The company also engages in contract manufacturing activities; and provides orthocare services. Its products are used in hospitals, laboratories, clinics, blood banks, and donor centers. The company was founded in 1939 and is headquartered in Raritan, New Jersey. .

Frequently asked questions

What percentage of Ortho Clinical Diagnostics Holdings plc is owned by insiders or institutions?
Currently 0.453% of Ortho Clinical Diagnostics Holdings plc shares are held by insiders and 99.59% by institutions. How many people work for Ortho Clinical Diagnostics Holdings plc?
Latest data suggests 4,500 work at Ortho Clinical Diagnostics Holdings plc. When does the fiscal year end for Ortho Clinical Diagnostics Holdings plc?
Ortho Clinical Diagnostics Holdings plc's fiscal year ends in December. Where is Ortho Clinical Diagnostics Holdings plc based?
Ortho Clinical Diagnostics Holdings plc's address is: 1001 Route 202, Raritan, NJ, United States, 08869